Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Graco Inc. stock logo
GGG
Graco
$83.50
-6.5%
$91.23
$68.78
$94.77
$14.07B0.81646,218 shs1,459 shs
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
$32.35
0.0%
$34.10
$26.81
$44.24
$1.24B1.2106,707 shs98,312 shs
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$46.65
+1.4%
$43.52
$32.69
$52.69
$932.53M0.72136,763 shs103,593 shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Graco Inc. stock logo
GGG
Graco
-0.19%+1.05%-4.44%+5.63%+27.48%
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
-0.19%+5.24%+0.09%-17.26%+4.15%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
+1.41%+4.36%+12.09%+19.19%+8.74%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Graco Inc. stock logo
GGG
Graco
3.5271 of 5 stars
1.33.04.22.41.92.51.3
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
0.4387 of 5 stars
0.54.00.80.01.44.20.0
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
1.3839 of 5 stars
2.50.00.80.01.14.21.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Graco Inc. stock logo
GGG
Graco
2.50
Moderate Buy$84.801.56% Upside
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
1.00
Sell$20.00-38.18% Downside
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
3.00
Buy$53.0013.61% Upside

Current Analyst Ratings

Latest MMI, GGG, SLP, and AVZ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
1/31/2024
Graco Inc. stock logo
GGG
Graco
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$91.00 ➝ $93.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Graco Inc. stock logo
GGG
Graco
$2.20B6.41$3.32 per share25.17$13.23 per share6.31
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
$645.93M1.92N/AN/A$16.81 per share1.92
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$59.58M15.65$0.84 per share55.53$8.86 per share5.27

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Graco Inc. stock logo
GGG
Graco
$506.51M$2.9428.4025.152.8523.07%24.61%19.68%N/A
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
-$34.03M-$0.89N/AN/A-5.27%-5.16%-3.83%5/8/2024 (Confirmed)
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$9.96M$0.5388.02N/A16.22%7.95%7.35%7/4/2024 (Estimated)

Latest MMI, GGG, SLP, and AVZ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
N/AN/AN/AN/AN/AN/A  
4/24/2024Q1 2024
Graco Inc. stock logo
GGG
Graco
$0.74$0.65-$0.09$0.59$536.19 million$492.19 million    
4/3/2024Q2 2024
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.18$0.20+$0.02$0.20$17.31 million$18.31 million      
2/16/202412/31/2023
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
-$0.28-$0.27+$0.01-$0.27N/A$166.24 million    
1/29/2024Q4 2023
Graco Inc. stock logo
GGG
Graco
$0.79$0.80+$0.01$0.96$565.86 million$566.64 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Graco Inc. stock logo
GGG
Graco
$1.021.22%+10.33%34.69%28 Years
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
$0.501.55%N/AN/A N/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.240.51%N/A45.28%N/A

Latest MMI, GGG, SLP, and AVZ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/3/2024
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Quarterly$0.060.5%4/26/20244/29/20245/6/2024
2/16/2024
Graco Inc. stock logo
GGG
Graco
quarterly$0.25501.2%4/12/20244/15/20245/1/2024
2/9/2024
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
Semi-Annual$0.251.3%3/11/20243/12/20244/5/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Graco Inc. stock logo
GGG
Graco
N/A
3.46
2.35
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
N/A
3.74
3.74
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
N/A
8.81
8.81

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Graco Inc. stock logo
GGG
Graco
93.88%
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
62.78%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
78.08%

Insider Ownership

CompanyInsider Ownership
Graco Inc. stock logo
GGG
Graco
2.63%
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
39.20%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
20.90%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Graco Inc. stock logo
GGG
Graco
4,000168.51 million164.08 millionOptionable
Marcus & Millichap, Inc. stock logo
MMI
Marcus & Millichap
89638.41 million23.35 millionOptionable
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
19219.99 million15.81 millionOptionable

MMI, GGG, SLP, and AVZ Headlines

SourceHeadline
Simulations Plus Inc.Simulations Plus Inc.
wsj.com - April 17 at 5:46 PM
Simulations Plus (NASDAQ:SLP): Promising Potential in Biotech SoftwareSimulations Plus (NASDAQ:SLP): Promising Potential in Biotech Software
msn.com - April 16 at 11:14 AM
SLP Sep 2024 55.000 callSLP Sep 2024 55.000 call
finance.yahoo.com - April 15 at 6:31 PM
New AI Bot Predicts These 7 Stocks Will Mint MillionairesNew AI Bot Predicts These 7 Stocks Will Mint Millionaires
investorplace.com - April 12 at 1:53 PM
Simulations Plus, Inc. (NASDAQ:SLP) Shares Acquired by Conestoga Capital Advisors LLCSimulations Plus, Inc. (NASDAQ:SLP) Shares Acquired by Conestoga Capital Advisors LLC
marketbeat.com - April 10 at 3:54 PM
Simulations Plus (NASDAQ:SLP) Stock Price Up 5.2%Simulations Plus (NASDAQ:SLP) Stock Price Up 5.2%
marketbeat.com - April 8 at 2:30 PM
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDASimulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
zacks.com - April 8 at 10:10 AM
Simulations Plus, Inc. (SLP) Q2 2024 Earnings Call TranscriptSimulations Plus, Inc. (SLP) Q2 2024 Earnings Call Transcript
seekingalpha.com - April 6 at 3:58 PM
Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This YearEarnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year
finance.yahoo.com - April 6 at 10:39 AM
Simulations Plus Second Quarter 2024 Earnings: Beats ExpectationsSimulations Plus Second Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - April 5 at 9:07 AM
Simulations Plus, Inc. to Issue Quarterly Dividend of $0.06 (NASDAQ:SLP)Simulations Plus, Inc. to Issue Quarterly Dividend of $0.06 (NASDAQ:SLP)
marketbeat.com - April 5 at 7:30 AM
Simulations Plus Shares Rise 27% Following FDAs License Renewal for Dilisym Software PlatformSimulations Plus Shares Rise 27% Following FDA's License Renewal for Dilisym Software Platform
marketwatch.com - April 4 at 11:06 PM
Simulations Plus (NASDAQ:SLP) Shares Gap Up  After Strong EarningsSimulations Plus (NASDAQ:SLP) Shares Gap Up After Strong Earnings
marketbeat.com - April 4 at 1:20 PM
Simulations Plus stock jumps 25% amid FDA renewal, earnings reportSimulations Plus stock jumps 25% amid FDA renewal, earnings report
msn.com - April 4 at 1:05 PM
Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call TranscriptSimulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript
finance.yahoo.com - April 4 at 1:05 PM
Simulations Plus (NASDAQ:SLP) Posts Quarterly  Earnings Results, Beats Expectations By $0.02 EPSSimulations Plus (NASDAQ:SLP) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS
marketbeat.com - April 4 at 11:58 AM
U.S. FDA Renews DILIsym® Software Licenses for 7th YearU.S. FDA Renews DILIsym® Software Licenses for 7th Year
businesswire.com - April 4 at 8:30 AM
Q2 2024 Simulations Plus Inc Earnings CallQ2 2024 Simulations Plus Inc Earnings Call
finance.yahoo.com - April 4 at 8:04 AM
Simulations Plus (SLP) Q2 Earnings & Revenues Beat EstimatesSimulations Plus (SLP) Q2 Earnings & Revenues Beat Estimates
zacks.com - April 4 at 7:36 AM
Simulations Plus, Inc. 2024 Q2 - Results - Earnings Call PresentationSimulations Plus, Inc. 2024 Q2 - Results - Earnings Call Presentation
seekingalpha.com - April 3 at 11:16 PM
SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q2 2024SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q2 2024
investorplace.com - April 3 at 10:05 PM
Simulations Plus: Fiscal Q2 Earnings SnapshotSimulations Plus: Fiscal Q2 Earnings Snapshot
washingtonpost.com - April 3 at 9:01 PM
Simulations Plus Inc (SLP) Aligns with EPS Projections and Maintains Full-Year GuidanceSimulations Plus Inc (SLP) Aligns with EPS Projections and Maintains Full-Year Guidance
finance.yahoo.com - April 3 at 9:01 PM
Simulations Plus (SLP) Q2 Earnings and Revenues Surpass EstimatesSimulations Plus (SLP) Q2 Earnings and Revenues Surpass Estimates
zacks.com - April 3 at 6:21 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Graco logo

Graco

NYSE:GGG
Graco Inc. designs, manufactures, and markets systems and equipment used to move, measure, control, dispense, and spray fluid and powder materials worldwide. The Contractor segment offers sprayers to apply paint to walls and other structures; two-component proportioning systems that are used to spray polyurethane foam and polyurea coatings; and viscous coatings to roofs, as well as markings on roads, parking lots, athletic fields, and floors. The Industrial segment provides liquid finishing equipment, paint circulating and supply pumps, paint circulating advanced control systems, plural component coating proportioners, and accessories and spare parts; equipment that pumps, meters, mixes and dispenses sealant, adhesive, and composite materials; and gel-coat equipment, chop and wet-out systems, resin transfer molding systems and applicators, and precision dispensing solutions. It also offers powder finishing products to coat powder finishing on metals under the Gema and SAT brands. The Process segment provides pumps to move and dispense chemicals, water, wastewater, petroleum, food, lubricants, and other fluids; pressure valves used in the oil and natural gas industry, other industrial processes, and research facilities; and chemical injection pumping solutions for injection of chemicals into producing oil wells and pipelines. It also supplies pumps, hose reels, meters, valves, and accessories for fast oil change facilities, service garages, fleet service centers, automobile dealerships, auto parts stores, truck builders, and heavy equipment service centers; and systems, components, and accessories for the automatic lubrication of bearings, gears, and generators in industrial and commercial equipment, compressors, turbines, and on- and off-road vehicles. It sells its products through distributors, original equipment manufacturers, and home center channels, as well as to end-users. The company was incorporated in 1926 and is headquartered in Minneapolis, Minnesota.
Marcus & Millichap logo

Marcus & Millichap

NYSE:MMI
Marcus & Millichap, Inc., an investment brokerage company, provides real estate investment brokerage and financing services to sellers and buyers of commercial real estate in the United States and Canada. The company offers commercial real estate investment sales, financing, research, and advisory services for multifamily, retail, office, industrial, single-tenant net lease, seniors housing, self-storage, hospitality, medical office, and manufactured housing, as well as capital markets. It also operates as a financial intermediary that provides commercial real estate capital markets solutions, including senior debt, mezzanine debt, joint venture, and preferred equity, as well as loan sales and consultative/due diligence services to commercial real estate owners, developers, investors, and capital providers. In addition, the company provides research, advisory, and consulting services, which include opinions of value, operating and financial performance benchmarking analysis, specific asset buy-sell strategies, market and submarket analysis and ranking, portfolio strategies by property type, market strategy, development and redevelopment feasibility studies, and other services for developers, lenders, owners, real estate investment trusts, high-net-worth individuals, pension fund advisors, and other institutions. Marcus & Millichap, Inc. was founded in 1971 and is headquartered in Calabasas, California.
Simulations Plus logo

Simulations Plus

NASDAQ:SLP
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.